Clinical Trials Directory

Trials / Terminated

TerminatedNCT03055481

A Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice

A Prospective Multicenter Non-inferiority Randomized Controlled Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Nagoya University · Academic / Other
Sex
All
Age
2 Days – 4 Days
Healthy volunteers
Not accepted

Summary

The aim of this trial is to show that the low irradiance level is not worse than the high irradiance level in the phototherapy for neonatal jaundice.

Detailed description

Neonatal jaundice is a commonly disease. Phototherapy is performed to prevent from kernicterus.However, light sources and irradiance level are different among hospitals, and it was controversial whether the improvement of jaundice is related to the irradiance level of phototherapy or not. In addition, long-term side effects are not clear, therefore, excessive irradiation should be avoided. The purpose of this study is to show that the low irradiance level is not worse than the high irradiance level in the phototherapy for neonatal jaundice. This study is multicenter randomized controlled trial conducted by Nagoya University Hospital, Anjo Kosei Hospital, Kasugai Municipal Hospital, Handa Hospital, TOYOTA Memorial Hospital, National Hospital Organization Nagoya Medical Center, Japan Red Cross Nagoya Daiichi Hospital, Hekinan Municipal Hospital, and Ogaki Municipal Hospital.

Conditions

Interventions

TypeNameDescription
OTHERHigh irradiance level of phototherapyHigh irradiance level of phototherapy: the target irradiance level is 30-35uW per square centimeter per nanometer of wavelength.
OTHERLow irradiance level of phototherapyLow irradiance level of phototherapy: the target irradiance level is 12-15uW per square centimeter per nanometer of wavelength

Timeline

Start date
2017-07-01
Primary completion
2022-01-31
Completion
2022-01-31
First posted
2017-02-16
Last updated
2023-10-03

Locations

8 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT03055481. Inclusion in this directory is not an endorsement.